$JNJ · Johnson & Johnson

This Form 4 reports transactions by Timothy Schmid, an executive vice president and worldwide chair of MedTech at Johnson & Johnson. On September 2, 2026, he exercised two employee stock option awards. The first covered 11,070 shares at an exercise price of $131.94 per share, and the second covered 22,527 shares at $151.41 per share. Both option awards were granted under the company’s Long-Term Incentive Plan and vested on the third anniversary of their grant dates.

On the same day, Schmid sold all 33,597 shares acquired through those option exercises at a price of $274.74 per share. After these transactions, he directly owned 25,447 shares of Johnson & Johnson common stock. The filing also lists small indirect holdings of 758 shares through a 401(k) plan and 46 shares through an employee stock ownership plan, both reported as of August 31, 2026. The filing is a routine disclosure of changes in beneficial ownership under Section 16(a) of the Securities Exchange Act of 1934.